SPI
18.219,49
PKT
+34,44
PKT
+0,19
%
Werbung
Analysen zu SPI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 14.09.12 | Lonza neutral | J.P. Morgan Cazenove | |
| 14.09.12 | ABB (Asea Brown Boveri) sell | Deutsche Bank AG | |
| 14.09.12 | UBS outperform | Exane-BNP Paribas SA | |
| 14.09.12 | ams-OSRAM buy | UBS AG | |
| 14.09.12 | SHL Telemedicine hold | Vontobel Research | |
| 13.09.12 | ABB (Asea Brown Boveri) buy | Citigroup Corp. | |
| 13.09.12 | Swiss Re overweight | J.P. Morgan Cazenove | |
| 13.09.12 | Swatch (I) outperform | Credit Suisse Group | |
| 13.09.12 | ABB (Asea Brown Boveri) buy | UBS AG | |
| 13.09.12 | ABB (Asea Brown Boveri) hold | Société Générale Group S.A. (SG) | |
| 13.09.12 | UBS buy | Nomura | |
| 13.09.12 | Novartis reduce | Vontobel Research | |
| 13.09.12 | Holcim hold | Vontobel Research | |
| 13.09.12 | Swiss Prime Site hold | Vontobel Research | |
| 13.09.12 | ABB (Asea Brown Boveri) buy | Vontobel Research | |
| 13.09.12 | Swiss Prime Site buy | Sarasin Research | |
| 12.09.12 | Novartis neutral | J.P. Morgan Cazenove | |
| 12.09.12 | TX Group buy | Sarasin Research | |
| 12.09.12 | TX Group hold | Vontobel Research | |
| 11.09.12 | Burckhardt Compression hold | Vontobel Research | |
| 11.09.12 | Givaudan outperform | Exane-BNP Paribas SA | |
| 11.09.12 | Newron PharmaceuticalsAz. buy | Vontobel Research | |
| 11.09.12 | Novartis underperform | Banc of America Securities-Merrill Lynch | |
| 11.09.12 | Novartis outperform | Sanford C. Bernstein and Co., Inc. | |
| 11.09.12 | Roche outperform | Sanford C. Bernstein and Co., Inc. | |
| 10.09.12 | Swisscom hold | Deutsche Bank AG | |
| 10.09.12 | Nestlé buy | Sarasin Research | |
| 10.09.12 | Roche buy | Banc of America Securities-Merrill Lynch | |
| 10.09.12 | Nestlé kaufen | Norddeutsche Landesbank (Nord/LB) | |
| 10.09.12 | Geberit hold | Vontobel Research | |
| 10.09.12 | Mikron hold | Vontobel Research | |
| 10.09.12 | Newron PharmaceuticalsAz. buy | Vontobel Research | |
| 10.09.12 | Swisscom hold | Vontobel Research | |
| 10.09.12 | Emmi buy | Sarasin Research | |
| 10.09.12 | LEM hold | Vontobel Research | |
| 10.09.12 | Swiss Re buy | Vontobel Research | |
| 07.09.12 | Avolta (ex Dufry) buy | Deutsche Bank AG | |
| 07.09.12 | Roche outperform | Exane-BNP Paribas SA | |
| 07.09.12 | Holcim outperform | Exane-BNP Paribas SA | |
| 07.09.12 | Novartis neutral | J.P. Morgan Cazenove |